Skip to main content
. 2021 Sep 27;12:744527. doi: 10.3389/fendo.2021.744527

Table 2.

Summary of critical steps for BMAd and BMSC isolation to highlight differences between protocols.

Main steps EDIN TOUL LILL LAUS PRAG
Material
Bone site of sampling Femoral proximal metaphysis and diaphysis
Femoral head
Femoral proximal metaphysis and diaphysis Trabecular bone from distal femoral epiphysis Femoral head (epiphysis + variable quantity of metaphysis)
Iliac crest
Iliac crest
Sample type BM aspirates BM aspirates Cancellous bone BM aspirates BM aspirates
Final material obtained BMAds BMAds BMAds BMSCs and BMAd-enriched fraction BMSCs and BMAd-enriched fraction
Digestion
Buffer KRH, 5.5 mM glucose
3% BSA
PBS
2% BSA
DMEM, 5.5 mM glucose
3% BSA
DMEM, 10% FBS -
Collagenase type, manufacturer (reference number) Type 1, Worthington Biochemicals (LS004196) from C. histolyticum, Sigma Aldrich (C6885) NB 4 standard grade, SERVA Electrophoresis (17454) Type I, Gibco (#17100-017) -
Collagenase concentration 250 UI/mL 0.2 to 0.3 UI/mL 1 UI/ml -
Digestion time 45min Max. 20 min 15-30 min 45 min -1h -
Washing
Buffer KRBH 5.5 mM glucose KRBH
0.5% BSA
DMEM, 5.5 mM glucose/
3% BSA
PBS/1% BSA PBS/1% BSA

Different protocols have been set up to isolate BMAds (from 3 institutes: EDIN, TOUL, LILL) or BMSCs (from 2 institutes: LAUS, PRAG). Differences related to biological material, digestion and washing parameters are highlighted.

Abbrevations referring to institute cities of members within BMAS Biobanking WG. EDIN: Edinburgh (WC); TOUL: Toulouse (CA); LILL: Lille (SL), LAUS: Lausanne (ON); PRAG: Prague (MT).